Does DANTROLENE Cause Hyperthermia malignant? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Hyperthermia malignant have been filed in association with DANTROLENE (Dantrolene Sodium). This represents 3.7% of all adverse event reports for DANTROLENE.
11
Reports of Hyperthermia malignant with DANTROLENE
3.7%
of all DANTROLENE reports
5
Deaths
6
Hospitalizations
How Dangerous Is Hyperthermia malignant From DANTROLENE?
Of the 11 reports, 5 (45.5%) resulted in death, 6 (54.5%) required hospitalization, and 3 (27.3%) were considered life-threatening.
Is Hyperthermia malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DANTROLENE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does DANTROLENE Cause?
Drug ineffective (74)
Neuroleptic malignant syndrome (50)
Off label use (30)
Respiratory failure (20)
Drug ineffective for unapproved indication (18)
Nausea (17)
Dizziness (15)
Pyrexia (15)
Asthenia (14)
Decreased appetite (14)
What Other Drugs Cause Hyperthermia malignant?
SUCCINYLCHOLINE (276)
SEVOFLURANE (207)
PROPOFOL (205)
FORANE (170)
ROCURONIUM (114)
FENTANYL (107)
SEVOFLURANE, USP (93)
ISOFLURANE (87)
MIDAZOLAM (62)
CISATRACURIUM (60)
Which DANTROLENE Alternatives Have Lower Hyperthermia malignant Risk?
DANTROLENE vs DAPAGLIFLOZIN
DANTROLENE vs DAPAGLIFLOZIN PROPANEDIOL
DANTROLENE vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DANTROLENE vs DAPRODUSTAT
DANTROLENE vs DAPSONE